## Clinical Diagnosis **Key Point:** This patient has enteric fever (typhoid fever) confirmed by positive blood culture and compatible clinical presentation (sustained fever, headache, rose spots, hepatosplenomegaly, constipation). ## Diagnostic Confirmation The blood culture isolate is the gold standard for diagnosis. Widal test positivity alone is NOT diagnostic in endemic areas due to high background seropositivity from previous infection or vaccination [cite:Harrison 21e Ch 197]. ## Antibiotic Selection Strategy **High-Yield:** The critical next step is **susceptibility testing** of the blood culture isolate to guide therapy. This determines: | Resistance Pattern | First-Line Agent | Alternative | | --- | --- | --- | | Fully susceptible | Chloramphenicol, ampicillin, or TMP-SMX | Ceftriaxone | | Multidrug-resistant (MDR) | Fluoroquinolone (e.g., ciprofloxacin) | Ceftriaxone | | Fluoroquinolone-resistant | Ceftriaxone or azithromycin | Carbapenems | | Extensively drug-resistant (XDR) | Carbapenems or azithromycin | Cephalosporins | **Clinical Pearl:** In India, MDR and fluoroquinolone-resistant *Salmonella typhi* are increasingly common. Empiric therapy should cover these patterns until susceptibilities return. ## Why Susceptibility Testing is Essential 1. Resistance patterns vary geographically and temporally 2. Empiric therapy may be suboptimal 3. Susceptibility results guide definitive, targeted therapy 4. Reduces unnecessary broad-spectrum antibiotic use **Warning:** Widal test positivity does NOT indicate current infection or antibiotic susceptibility—it only confirms exposure.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.